Catalyst Wire Dossier Catalyst Wire Dossier

TZP-102

· Tranzyme, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TZP-102, covering 2012-12-11 to 2013-04-25. Get the full timeline:

Most recent: Clinical Trial Update: Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis [Phase 2]

See pricing